创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology IC50 Platform: An Innovative Force for Drug Discovery and Life Science Research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-10-15 16:02
  • Views:

(Summary description)In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.

InnoModels Biotechnology IC50 Platform: An Innovative Force for Drug Discovery and Life Science Research

(Summary description)In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-10-15 16:02
  • Views:
Information

In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
Core advantages of IC50 platform
1、Professional team and rich experience
InnoModels Biotechnology has a professional team with more than 15 years of experience in IC50 and cell culture. These lab technicians not only specialize in IC50 assay and cell culture technology, but also have accumulated rich knowledge and experience in the field of cell activity detection. Their professional background and rigorous attitude ensure the accuracy and reliability of every experimental result.
2、Abundant cell resources
The platform has more than 400 human-derived tumor cell lines, covering a wide range of cancer types and subtypes. This comprehensive cell bank resource enables researchers to easily select cell lines suitable for their research needs, whether for anti-cancer drug screening or mechanism research.
3、Strict quality control
InnoModels Biotechnology attaches great importance to the quality of data and the safety of experiments. All cells are tested for STR (Short Tandem Repeat Sequence) before use to ensure the accuracy of cell identity. In addition, the platform regularly tests for mycoplasma and chlamydia in the cell culture solution to ensure the reliability and safety of the experiments. This strict quality control system provides researchers with reliable data assurance.

 


Technical applications of IC50 platform
1、Drug R&D
In the field of drug discovery and development, the IC50 platform helps researchers evaluate the inhibitory effect of potential drug candidates by accurately measuring the half-maximal effect concentration (IC50 value) of a drug on cell growth inhibition. This technology not only optimizes the drug design and development process, but also improves the success rate of new drug development.
2. Life science research
In life science research, the determination of IC50 values is important for in-depth understanding of the functions and interactions of biomolecules. By providing reliable IC50 value data, the IC50 platform of InnoModels provides researchers with an important research tool. The platform is also widely used in the field of toxicology research to assess the toxicity of compounds in living organisms.
Looking into the future
With the continuous progress of science and technology and the in-depth development of life science, InnoModels Biotechnology will continue to utilize the advantages of its IC50 platform to provide researchers with more efficient and reliable experimental solutions. At the same time, the company will continue to innovate and optimize its technology platform to meet the growing needs of scientific research.
In conclusion, with its core advantages such as professional team, abundant resources, strict quality control and wide range of application areas, the IC50 platform of InnoModels Biotechnology is gradually becoming an important force in promoting drug discovery and life science innovation. In the future development, we have reason to believe that the platform will continue to play an important role and contribute more wisdom and strength to the scientific research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司